Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-12-03FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an Original Application for Metformin Hydrochloride from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), enabling t…
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes [NA]
A completed clinical trial assessing how a study medication affects exercise function in individuals with Type 2 Diabetes, with results post…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) [Phase 3]
Phase 3 trial assessing efficacy and safety of efpeglenatide versus placebo in adults with type 2 diabetes inadequately controlled with basa…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea [Phase 3]
Phase 3 trial evaluating efpeglenatide versus placebo in type 2 diabetes patients inadequately controlled with metformin (±sulfonylurea) was…
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients [Phase 3]
A Phase 3 trial comparing Tropicamide 0.5% versus Tropicamide 1% on intraocular pressure in patients with diabetes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021 [Phase 4]
Phase 4 trial update on efficacy and safety of a recombinant human insulin patch.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM)
A completed validation study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM) conducted by The Cleveland Clinic; results pos…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) [NA]
A completed clinical trial (FITEST) evaluating financial incentives combined with telephone education and skills training for African Americ…
-
FDA approval · 2021-11-04FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2021-11-04FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2021-11-04FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC, marking a labeli…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Liraglutide Hospital Discharge Trial [Phase 4]
Phase 4 clinical trial update for liraglutide in patients with Type 2 diabetes; results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin [Phase 3]
Phase 3 trial comparing Efpeglenatide to Dulaglutide in adults with Type 2 Diabetes mellitus inadequately controlled on metformin; study ter…
-
FDA approval · 2021-10-22FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The action updates/expands the drug's approved l…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing two weekly doses of semaglutide in adults with type 2 diabetes has completed, with results posted.
-
FDA approval · 2021-10-20FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. to update the…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone [Phase 3]
Phase 3 trial update for tirzepatide in adults with type 2 diabetes not controlled by diet and exercise, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT [Phase 4]
A Phase 4 trial evaluating different initial insulin dose regimens and their effect on time to glycemic target achievement and treatment saf…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) [Phase 2]
Phase 2 clinical trial investigating how the microbiome affects insulin sensitivity; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Effect of Efpeglenatide on Cardiovascular Outcomes [Phase 3]
Phase 3 trial update for efpeglenatide assessing cardiovascular outcomes in type 2 diabetes patients has been terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Remission Through Early Monitored Insulin Therapy - Duration Month [Phase 4]
Phase 4 clinical trial on early monitored insulin therapy for type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating the effects of PCSK9 inhibition with evolocumab on postprandial lipid metabolism in patients with type 2 diabetes.
-
CLINICAL_TRIALS withdrawal · 2021-10-11Clinical Trial Update: Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Phase 4]
A Phase 4 clinical trial evaluating metformin and sitagliptin in adults with type 2 diabetes has been withdrawn. No results reported.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Renohemodynamic Effects of Combined empagliflOzin and LosARtan [Phase 4]
Phase 4 trial updating Reno hemodynamic effects of combined empagliflozin and losartan in type 2 diabetes and diabetic kidney disease.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control [Phase 4]
A Phase 4 trial investigating continuation of metformin to improve perioperative glycemic control; the study is withdrawn.